Galectin Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.20
|
-0.14
|
0.06
|
30.00%
|
|
2022-06-30
|
-0.19
|
-0.16
|
0.03
|
15.79%
|
|
2022-03-31
|
-0.14
|
-0.17
|
-0.03
|
-21.43%
|
|
2021-12-31
|
-0.19
|
-0.12
|
0.07
|
36.84%
|
|
2021-09-30
|
-0.18
|
-0.14
|
0.04
|
22.22%
|
|
2021-06-30
|
-0.18
|
-0.15
|
0.03
|
16.67%
|
|
2021-03-31
|
-0.17
|
-0.11
|
0.06
|
35.29%
|
|
2020-12-31
|
-0.16
|
-0.13
|
0.03
|
18.75%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.47
|
|
2021-12-31
|
-0.52
|
|
2020-12-31
|
-0.40
|
|
2019-12-31
|
-0.43
|
|
2018-12-31
|
-0.38
|
|
2017-12-31
|
-0.49
|
|
2016-12-31
|
-0.75
|
|
2015-12-31
|
-0.88
|
|
2014-12-31
|
-0.77
|
|
2013-12-31
|
-0.77
|
|
2012-12-31
|
-0.72
|
|
2011-12-31
|
-1.07
|
|
2010-12-31
|
-0.96
|
|
2009-12-31
|
-1.54
|
|
2007-12-31
|
-3.46
|
|
2005-12-31
|
-2.63
|
|
2003-12-31
|
-1.36
|
|
2002-12-31
|
-0.66
|